BiotechTube

AK102 + AK102 + Placebo + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
76
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperlipidemia

Conditions

Hyperlipidemia

Trial Timeline

Nov 3, 2021 → Jun 22, 2022

NCT ID
NCT05255094

About AK102 + AK102 + Placebo + Placebo

AK102 + AK102 + Placebo + Placebo is a phase 3 stage product being developed by Akeso for Hyperlipidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT05255094. Target conditions include Hyperlipidemia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05255094Phase 3Completed

Competing Products

20 competing products in Hyperlipidemia

See all competitors
ProductCompanyStageHype Score
VK2809 + PlaceboViking TherapeuticsPhase 2
47
YHP1701 + YHR1703 + YHR1704YuhanPhase 3
77
YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placeboYuhanPhase 3
77
Diet+pravastatinDaiichi SankyoApproved
85
Bempedoic acid 180 mg tabletDaiichi SankyoApproved
85
Minute Maid Heart Wise orange juice + WelcholDaiichi SankyoApproved
85
Pravafen + Pravastatin + FenofibrateShionogiPhase 3
77
Evacetrapib + Atorvastatin + Ezetimibe + PlaceboEli LillyPhase 3
77
exenatideEli LillyPre-clinical
23
LY3015014 IV + Placebo IV + LY3015014 SC + Placebo SCEli LillyPhase 1
33
SHR-1209 single-site subcutaneous injection + SHR-1209 multiple-site subcutaneous injectionsJiangsu Hengrui MedicinePhase 1
33
SHR-1209Jiangsu Hengrui MedicinePhase 1
33
SHR-1209 + PlaceboJiangsu Hengrui MedicinePhase 1/2
41
Rosuvastatin + AtorvastatinAstraZenecaPhase 2
52
Rosuvastatin (Crestor)AstraZenecaApproved
85
simvastatin + EzetimibeMerckApproved
85
MK-0524A + Atorvastatin + SimvastatinMerckPhase 3
77
simvastatin 20 mg/ezetimibeMerckPhase 2/3
65
Enlicitide + Rosuvastatin + Placebo for Enlicitide + Placebo for RosuvastatinMerckPhase 3
77
Sitagliptin + PlaceboMerckPhase 2/3
65

Other Products from Akeso

AK104(SC) + AK104(IV) + Capecitabine + Oxaliplatin injectionPhase 3
76
AK111 + AK111 + PlaceboPhase 3
76
AK104 + LenvatinibPhase 3
76
Cadonilimab (AK104) + Oxaliplatin + Capecitabine + 5- Fluorouracil + Calcium FolinatePhase 3
76
Penpulimab + placeboPhase 3
76